NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

BDSX

Biodesix Inc

Jul 03 • 04:00PM ET

0.2716

Dollar change -0.0034
Percentage change -1.24	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BEAM CDNA FLGT GH EXAS QDEL TWST CRSP PACB

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.29	Insider Own	52.65%	Shs Outstand	146.44M	Perf Week	-1.84%
Market Cap	39.81M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	6.30%	Shs Float	69.40M	Perf Month	-9.65%
Enterprise Value	84.39M	PEG	-	EPS next Q	-0.07	Inst Own	36.42%	Short Float	7.58%	Perf Quarter	-56.73%
Income	-40.42M	P/S	0.53	EPS this Y	26.46%	Inst Trans	-10.39%	Short Ratio	0.59	Perf Half Y	-81.40%
Sales	74.46M	P/B	3.60	EPS next Y	40.02%	ROA	-46.61%	Short Interest	5.26M	Perf YTD	-82.25%
Book/sh	0.08	P/C	2.25	EPS next 5Y	33.97%	ROE	-1454.41%	52W High	2.04 -86.69%	Perf Year	-82.25%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	40.57% 69.26%	ROIC	-55.96%	52W Low	0.17 58.09%	Perf 3Y	-80.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.38% 23.77%	Gross Margin	78.38%	Volatility	9.52% 9.13%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.13	EPS Y/Y TTM	47.48%	Oper. Margin	-43.47%	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.14	Sales Y/Y TTM	35.76%	Profit Margin	-54.28%	RSI (14)	42.49	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	2.22	EPS Q/Q	45.90%	SMA20	-4.33%	Beta	0.96	Target Price	1.80
Payout	-	Debt/Eq	5.63	Sales Q/Q	21.19%	SMA50	-21.88%	Rel Volume	0.06	Prev Close	0.28
Employees	273	LT Debt/Eq	5.53	Earnings	May 13 AMC	SMA200	-72.38%	Avg Volume	8.93M	Price	0.27
IPO	Oct 28, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.61% -7.51%	Trades		Volume	500,362	Change	-1.24%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy	$3
May-13-24	Initiated	TD Cowen	Buy	$2.80
May-03-24	Initiated	Lake Street	Buy	$3
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$21 → $11
Nov-23-20	Initiated	William Blair	Outperform
Nov-23-20	Initiated	Morgan Stanley	Overweight	$20
Nov-23-20	Initiated	Canaccord Genuity	Buy	$26
Nov-23-20	Initiated	BTIG Research	Buy	$22

Jun-10-25 06:17AM	Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs (GlobeNewswire) +13.91%
May-22-25 05:03PM	Biodesix Announces New Data on the VeriStrat Test to be Presented at the 2025 ASCO Annual Meeting (GlobeNewswire) -9.92%
May-21-25 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire) +45.90%
May-15-25 06:00AM	Biodesix Announces New Clinical and Economic Data for its Nodify Lung Tests at ISPOR and ATS (GlobeNewswire)
May-14-25 04:01PM	Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award (GlobeNewswire) -38.74%
03:16AM	Loading…
03:16AM	Biodesix Inc (BDSX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Sales Team ... (GuruFocus.com)
May-13-25 05:15PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2025 Results and Highlights (GlobeNewswire)
May-12-25 09:50AM	Biodesix Inc (BDSX) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:25AM	Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-08-25 06:30PM	DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -17.91% +6.84%
Apr-30-25 07:45AM	GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-29-25 06:00AM	Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire) -6.51%
Apr-28-25 07:15AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks) +6.25%
Apr-25-25 07:15AM	Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates (Zacks) -5.64%
06:00AM	Loading…
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Mar-06-25 12:00PM	Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-04-25 05:20AM	Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey)
02:03AM	Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-25 04:01PM	Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire) -10.09%
Feb-28-25 07:15AM	Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-26-25 06:00AM	Biodesix to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-18-25 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (GlobeNewswire)
Jan-10-25 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) (GlobeNewswire) -14.19%
Jan-07-25 06:00AM	Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study (GlobeNewswire)
Nov-20-24 09:35AM	Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-02-24 03:01AM	Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
Nov-01-24 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -23.53%
06:00AM	Biodesix Announces Third Quarter 2024 Results and Highlights (GlobeNewswire)
Oct-31-24 09:06AM	What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings (GuruFocus.com)
06:00AM	Loading…
Oct-29-24 06:00AM	Biodesix to Participate in Three Investor Conferences in November (GlobeNewswire)
Oct-18-24 06:00AM	Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 (Business Wire)
Oct-07-24 06:00AM	Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study (Business Wire)
Sep-05-24 06:00AM	Biodesix to Present at Two Investor Conferences in September (Business Wire)
Aug-08-24 10:23AM	Q2 2024 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 06:05PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2024 Results and Highlights (Business Wire)
Aug-06-24 06:00AM	Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
Jul-24-24 06:00AM	Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jun-18-24 08:13AM	Biodesix Named to Inc. Magazine's 2024 "Best Workplaces" (Business Wire)
May-28-24 06:00AM	Biodesix to Participate in Two Investor Conferences in June (Business Wire)
May-21-24 06:00AM	Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting (Business Wire)
May-10-24 05:59PM	Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:55PM	Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
May-09-24 03:46AM	Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-24 09:00PM	BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management (Business Wire)
May-07-24 06:00AM	Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference (Business Wire)
Apr-24-24 06:00AM	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-09-24 05:00PM	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting (Business Wire) -9.93%
Apr-05-24 07:17AM	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement (Business Wire) -7.28%
Mar-25-24 06:00AM	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center (Business Wire)
Mar-04-24 09:04AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 10:40PM	Q4 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
06:31AM	Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin (GuruFocus.com)
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights (Business Wire)
Feb-26-24 06:00AM	Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-16-24 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 (Business Wire) -5.73%
Feb-13-24 03:00AM	Biodesix Inc CEO Scott Hutton Sells 64,390 Shares (GuruFocus.com)
Jan-26-24 09:04AM	3 Penny Stocks to Turn $999 Into $1 Million: January 2024 (InvestorPlace)
Nov-14-23 06:00AM	Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method (Business Wire)
Nov-09-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in November (Business Wire) -6.39%
Nov-07-23 04:01PM	Biodesix Announces Third Quarter 2023 Results and Highlights (Business Wire) -10.14%
Oct-24-23 06:00AM	Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) -5.00%
Oct-03-23 06:00AM	Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting (Business Wire)
Sep-07-23 06:00AM	Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer (Business Wire)
Sep-05-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -11.76%
Aug-22-23 06:00AM	Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer (Business Wire)
Aug-09-23 10:25AM	Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.62%
Aug-08-23 08:38AM	Q2 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2023 Results and Highlights (Business Wire)
Aug-01-23 06:00AM	Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire) +20.17%
Jul-26-23 07:58AM	Biodesix (NASDAQ:BDSX) investors are sitting on a loss of 49% if they invested a year ago (Simply Wall St.)
Jul-24-23 06:00AM	Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire)
Jul-12-23 06:00AM	Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules (Business Wire)
Jul-06-23 09:11AM	Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services (Business Wire)
Jun-27-23 06:00AM	Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier (Business Wire) -5.83%
Jun-01-23 06:00AM	Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting (Business Wire)
May-31-23 06:00AM	Biodesix to Participate in William Blairs 43rd Annual Growth Stock Conference (Business Wire)
May-28-23 08:09AM	Jack Schuler Spends US$65k On Biodesix Stock \ (Simply Wall St.)
May-25-23 06:00AM	Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing (Business Wire) +5.30%
May-24-23 06:00AM	Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors (Business Wire) +12.68%
May-18-23 07:00AM	Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference (Business Wire) -5.79%
May-12-23 11:10AM	Q1 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2023 Results and Highlights (Business Wire)
May-09-23 06:15PM	Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-27-23 06:00AM	Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-12-23 06:53AM	Insiders of Biodesix, Inc. (NASDAQ:BDSX) must be frustrated after market cap dropped US$16m since recent purchases (Simply Wall St.)
Mar-15-23 09:31AM	Bullish Biodesix, Inc. (NASDAQ:BDSX) insiders filled their treasuries with US$34m worth of stock over last year (Simply Wall St.) +15.24%
Mar-08-23 07:14AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.06%
Mar-06-23 07:25AM	Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.00%
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights (Business Wire)
Feb-28-23 06:00AM	Biodesix to Participate at Cowens 43rd Annual Healthcare Conference (Business Wire)
Feb-21-23 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Feb-16-23 06:27AM	Even after rising 15% this past week, Biodesix (NASDAQ:BDSX) shareholders are still down 39% over the past year (Simply Wall St.) +5.72%
Dec-19-22 06:00AM	Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test (Business Wire) +5.88%
Dec-16-22 04:01PM	Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors (Business Wire)

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULER JACK W	Director	May 16 '25	Buy	0.27	4,000,000	1,070,000	20,194,935	May 20 04:11 PM
SCHULER JACK W	Director	May 19 '25	Buy	0.34	723,239	246,624	20,918,174	May 20 04:11 PM
Vazquez Chris	Chief Accounting Officer	May 12 '25	Sale	0.36	112	40	18,113	May 13 06:36 PM
Vazquez Chris	Chief Accounting Officer	May 13 '25	Sale	0.35	112	40	18,001	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 12 '25	Sale	0.36	223	80	157,163	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 13 '25	Sale	0.35	222	78	156,941	May 13 06:36 PM
O'Kane Kieran	Chief Commercial Officer	May 12 '25	Sale	0.36	239	86	139,290	May 13 06:35 PM
O'Kane Kieran	Chief Commercial Officer	May 13 '25	Sale	0.35	238	84	139,052	May 13 06:35 PM
Hutton Scott	President & CEO	May 12 '25	Sale	0.36	1,888	679	722,271	May 13 06:35 PM
Hutton Scott	President & CEO	May 13 '25	Sale	0.35	1,887	666	720,384	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 12 '25	Sale	0.36	496	178	249,121	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 13 '25	Sale	0.35	496	175	248,625	May 13 06:35 PM
Vazquez Chris	Chief Accounting Officer	Feb 11 '25	Sale	0.92	3,630	3,355	17,623	Feb 12 05:12 PM
Pestano Gary Anthony	Chief Development Officer	Feb 11 '25	Sale	0.92	16,748	15,479	156,008	Feb 12 05:12 PM
O'Kane Kieran	Chief Commercial Officer	Feb 11 '25	Sale	0.92	17,527	16,198	128,039	Feb 12 05:11 PM
Hutton Scott	President & CEO	Feb 11 '25	Sale	0.92	83,660	77,319	701,947	Feb 12 05:11 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 11 '25	Sale	0.92	24,664	22,794	246,460	Feb 12 05:11 PM
Hutton Scott	Officer	Feb 11 '25	Proposed Sale	0.95	83,660	79,477		Feb 11 04:41 PM
Cowie Robin Harper	Officer	Feb 11 '25	Proposed Sale	0.95	24,664	23,431		Feb 11 04:41 PM
Pestano Gary Anthony	Officer	Feb 11 '25	Proposed Sale	0.95	16,748	15,911		Feb 11 04:41 PM
O'Kane Kieran	Officer	Feb 11 '25	Proposed Sale	0.95	17,527	16,651		Feb 11 04:40 PM
SCHULER JACK W	Director	Nov 21 '24	Buy	1.23	100,000	122,840	31,194,935	Nov 22 12:30 PM
Kennedy Lawrence T. Jr	Director	Nov 21 '24	Buy	1.16	35,000	40,562	10,411,024	Nov 22 12:30 PM
SCHULER JACK W	Director	Nov 20 '24	Buy	1.17	200,000	234,000	31,094,935	Nov 21 03:30 PM
Vazquez Chris	Chief Accounting Officer	Nov 11 '24	Sale	1.39	105	146	11,685	Nov 13 04:22 PM
Vazquez Chris	Chief Accounting Officer	Nov 12 '24	Sale	1.40	98	137	11,587	Nov 13 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Nov 11 '24	Sale	1.39	220	306	127,234	Nov 13 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Nov 12 '24	Sale	1.40	207	290	127,027	Nov 13 04:22 PM
O'Kane Kieran	Chief Commercial Officer	Nov 11 '24	Sale	1.39	238	331	97,672	Nov 13 04:21 PM
O'Kane Kieran	Chief Commercial Officer	Nov 12 '24	Sale	1.40	224	314	97,448	Nov 13 04:21 PM
Hutton Scott	President & CEO	Nov 11 '24	Sale	1.39	1,927	2,680	534,792	Nov 13 04:21 PM
Hutton Scott	President & CEO	Nov 12 '24	Sale	1.40	1,813	2,540	532,979	Nov 13 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 11 '24	Sale	1.39	500	695	203,807	Nov 13 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 12 '24	Sale	1.40	471	660	203,336	Nov 13 04:21 PM
Strobeck Matthew	Director	Nov 05 '24	Buy	1.40	40,000	55,916	2,606,879	Nov 06 03:16 PM
SCHULER JACK W	Director	Nov 05 '24	Buy	1.36	100,253	136,585	30,894,935	Nov 06 03:16 PM
PATIENCE JOHN	Chairman	Nov 05 '24	Buy	1.38	75,000	103,710	2,153,298	Nov 06 03:16 PM
MASSARANY HANY	Director	Nov 05 '24	Buy	1.37	22,500	30,865	53,364	Nov 06 03:15 PM
Kennedy Lawrence T. Jr	Director	Nov 05 '24	Buy	1.36	51,200	69,888	10,356,024	Nov 06 03:15 PM
Kennedy Lawrence T. Jr	Director	Nov 06 '24	Buy	1.36	20,000	27,180	10,376,024	Nov 06 03:15 PM
Vazquez Chris	Chief Accounting Officer	Aug 09 '24	Sale	1.60	155	248	11,242	Aug 12 07:24 PM
Vazquez Chris	Chief Accounting Officer	Aug 12 '24	Sale	1.57	54	85	11,188	Aug 12 07:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 09 '24	Sale	1.60	320	512	126,187	Aug 12 07:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 12 '24	Sale	1.57	111	174	126,076	Aug 12 07:24 PM
O'Kane Kieran	Chief Commercial Officer	Aug 09 '24	Sale	1.60	345	552	89,748	Aug 12 07:24 PM
O'Kane Kieran	Chief Commercial Officer	Aug 12 '24	Sale	1.57	120	189	89,628	Aug 12 07:24 PM
Hutton Scott	President & CEO	Aug 09 '24	Sale	1.60	2,781	4,452	519,331	Aug 12 07:23 PM
Hutton Scott	President & CEO	Aug 12 '24	Sale	1.57	963	1,514	518,368	Aug 12 07:23 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 09 '24	Sale	1.60	724	1,159	191,402	Aug 12 07:23 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 12 '24	Sale	1.57	251	395	191,151	Aug 12 07:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BDSX

Biodesix Inc

Upgrade your FINVIZ experience